Market closedNon-fractional

Innoviva/INVA

13:30
14:25
15:15
16:10
17:00
1D1W1MYTD1YMAX

About Innoviva

Innoviva Inc is a company with a portfolio of royalties and innovative healthcare assets. It has three primary sets of assets: a royalty portfolio, operating assets in critical care and infectious disease, and other strategic healthcare assets. Its product offering includes Relvar/Breo/Ellipta, Anoro, Ellipta, Trelegy, Ellipta and others.

Ticker

INVA

Sector

Healthcare

Trading on

NASDAQ

Industry

Pharmaceuticals

Headquarters

Burlingame, United States

Employees

112

Innoviva Metrics

BasicAdvanced
$1B
Market cap
7.25
P/E ratio
$2.25
EPS
0.58
Beta
-
Dividend rate
$1B
0.58
10.42
8.513
63.489
63.489
6.65%
7.14%
28.67%
7.248
3.369
1.47
2.24
6.904
-1.91%
-13.24%
-3.21%
-0.25%

What the Analysts think about Innoviva

Analyst Ratings

Majority rating from 1 analysts.
Hold

Innoviva Financial Performance

Income StatementBalance sheetCash Flow

Income Statement

Revenues and expenses
47.15% profit margin
QuarterlyAnnual
Q1 24
QoQ growth
Revenue
$77M
-9.79%
Net income
$37M
-40.65%
Profit margin
47.15%
-34.21%

Innoviva Earnings Performance

Earnings per share (EPS)

Company profitability
Beat by 170.59%
QuarterlyAnnual
Q2 23
Q3 23
Q4 23
Q1 24
Q2 24
Actual
$0.02
$0.98
$0.76
$0.46
-
Expected
$0.26
$0.27
$0.23
$0.17
$0.25
Surprise
-92.31%
262.96%
230.43%
170.59%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon
Market closedNon-fractional

Upcoming events

No upcoming events

FAQs

What’s the current market cap for Innoviva stock?

Innoviva (INVA) has a market cap of $1B as of July 05, 2024.

What is the P/E ratio for Innoviva stock?

The price to earnings (P/E) ratio for Innoviva (INVA) stock is 7.25 as of July 05, 2024.

Does Innoviva stock pay dividends?

No, Innoviva (INVA) stock does not pay dividends to its shareholders as of July 05, 2024.

When is the next Innoviva dividend payment date?

Innoviva (INVA) stock does not pay dividends to its shareholders.

What is the beta indicator for Innoviva?

Innoviva (INVA) has a beta rating of 0.58. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.

Buy or sell Innoviva stock

Buy or sell Innoviva stock

Stocks, funds and up to 4.50% interest earned on uninvested cash. When you invest, your capital is at risk.
Start investing